Invention Grant
- Patent Title: Oligonucleotides for the treatment of nucleotide repeat expansion disorders associated with MSH3 activity
-
Application No.: US17337172Application Date: 2021-06-02
-
Publication No.: US11408000B2Publication Date: 2022-08-09
- Inventor: Nessan Anthony Bermingham , Brian R. Bettencourt , Pei Ge
- Applicant: Triplet Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Triplet Therapeutics, Inc.
- Current Assignee: Triplet Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Sterne, Kessler, Goldstein & Fox P.L.L.C.
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12N15/113
Abstract:
The present disclosure features useful compositions and methods to treat nucleotide repeat expansion disorders, e.g., in a subject in need thereof. In some aspects, the compositions and methods described herein are useful in the treatment of disorders associated with MSH3 activity.
Public/Granted literature
- US20210395740A1 METHODS FOR THE TREATMENT OF NUCLEOTIDE REPEAT EXPANSION DISORDERS ASSOCIATED WITH MSH3 ACTIVITY Public/Granted day:2021-12-23
Information query
